ft 13 oct 93 ft export 14 trade balanc strengthen british powerhous success base abil discov develop market highli innov medicin paul abraham find export growth risen year pharmaceut industri uk pharmaceut industri one nation crown jewel second power gener machineri trade balanc surplu last year sector enjoy surplu pound 1 329bn even petroleum industri 1951 trade surplu pound 31m continu trade balanc success uk drug industri base export growth risen steadili past decad increas pound 978m 1982 pound 2 993bn last year lead export zeneca recent spun bioscienc busi imperi chemic industri although largest uk bioscienc compani substanti proport manufactur carri uk last year compani sell agrochem special chemic well medicin gener export pound 1 4bn compar pound 1 23bn previou year lead export includ glaxo europ largest pharmaceut group whose export rose 0 84 per cent pound 837m 1991 pound 844m last year brought oversea manufactur new product stream smithklin beecham anglo american healthcar group increas export 33 per cent pound 347m 1991 pound 462m last year compani say launch anti depress seroxat anti nausea product kytril uk pharmaceut export success gener uk base group also highli success british subsidiari multin corpor ciba swiss group run larg uk trade surplu export last year pound 294m import pound 79m although gener pharmaceut compani uk 41st largest export anoth swiss compani roch also run trade surplu export pound 112m compar import pound 67m lilli industri uk subsidiari eli lilli us uk 78th biggest export sale oversea pound 132m compar import pound 79m basi uk success remark abil discov develop market highli innov medicin accord associ british pharmaceut industri uk group success develop 420 new chemic entiti two world 10 top sell drug develop uk includ glaxo zantac world best sell medicin sale pound 2 1bn year howev rate import growth rise rapidli export growth wherea export exceed import factor four 1970 ratio last year 1 5 import increas pound 375m 1982 pound 1 663bn last year uk run drug trade deficit germani switzerland sweden exampl posit would wors uk domest market small per capita consumpt medicin dollar 46 first six month year accord im specialist market research compani figur franc doubl one reason increas penetr non uk medicin british doctor prescrib increas number drug oversea accord smithklin beecham third fourth fifth largest drug group sell uk ciba astra sweden bayer germani merck amp co us rhone poulenc rorer franco american group seventh eighth addit mani british group invest manufactur oversea dr joe blaker group technic director charg manufactur glaxo estim 10 year ago us market almost entir suppli product origin uk compani manufactur half volum outsid home countri group follow glaxo lead smithklin beecham manufactur site puerto rico singapor ireland uk first three countri offer signific tax break pharmaceut manufactur wellcom estim 65 per cent activ ingredi manufactur britain 40 per cent product finish british base group seem set discov innov product uk entir benefit success pharmaceut industri rank pharmaceut export chng 1992 compani 1992 91 10 zeneca 1 403 0 14 2 14 glaxo 844 0 0 8 24 smithklin beecham 462 0 33 1 31 wellcom 396 3 16 5 41 ciba geigi 294 0 3 0 47 fison 261 5 12 2 78 lilli industri 132 8 6 1 86 roch product 112 5 11 4 95 amersham int 95 5 5 2 total 4 001 6 10 7